Authors


James Pitcavage, MS

Latest:

Primary Care Diabetes Bundle Management: 3-Year Outcomes for Microvascular and Macrovascular Events

Using a system for primary care management of patients with diabetes may reduce the risk of myocardial infarction, stroke, and retinopathy over a 3-year period.


Paula K. Diehr, PhD

Latest:

Complementary and Alternative Medicine Provider Use and Expenditures by Cancer Treatment Phase

More than 26% of cancer patients see CAM providers, primarily for musculoskeletal problems; use does not vary by treatment phase, and associated expenditures are low.



Miriam Dickinson, PhD

Latest:

Cost of Delivering Centralized and Decentralized Reminder/Recall for Vaccinations to Children and Adolescents in an ACO

Centralized reminder/recall (R/R) is less costly to deliver than decentralized R/R for both children and adolescents when implemented for patients within an accountable care organization.


Jenifer Levinson

Latest:

Resource Utilization With Insulin Pump Therapy for Type 2 Diabetes Mellitus

A retrospective claims analysis of managed care enrollees with type 2 diabetes mellitus showed that insulin pump therapy reduced antidiabetic drug and healthcare resource use.


n A. Rodriguez, PharmD

Latest:

Impact of Statin Guidelines on Statin Utilization and Costs in an Employer-Based Primary Care Clinic

Adherence to clinical guidelines in practice is often suboptimal and controversial. This study compares actual statin utilization and cost with full adoption of major clinical guidelines in a real-world population.


Hilary K. Seligman, MD, MAS

Latest:

Food Insecurity, Healthcare Utilization, and High Cost: A Longitudinal Cohort Study

In a longitudinal study, the authors find that food insecurity is associated with greater emergency department visits, inpatient admissions, and length of stay. Check out our website’s new table/figure pop-up feature! Click on the name of a table or figure in the text to see it in your browser.


Gabriela Vazquez-Benitez, PhD, MSc

Latest:

Are Benefits From Diabetes Self-Management Education Sustained?

Conventional individualized diabetes self-management education resulted in sustained improvement in self-efficacy and diabetes distress. Short-term improvements in A1C, nutrition, and physical activity were not sustained.



Dana Drzayich Antol, MS

Latest:

Claims Identification of Patients With Severe Cancer-Related Symptoms

The authors established a claims-based mechanism for identifying patients with lung cancer with more severe patient-reported cancer-related symptoms who could benefit from engagement with health care programs.


Kevin P. Cohoon, DO, MSc

Latest:

Costs of Venous Thromboembolism Associated With Hospitalization for Medical Illness

Venous thromboembolism during or after recent hospitalization for medical illness contributes a substantial economic burden to society across all hospital and ambulatory care delivered.


Emily Carrier, MD

Latest:

Medical Cost Burdens Among Nonelderly Adults With Asthma

People with asthma face substantial out-of-pocket costs-even when they take medications to manage their illness. However, many choose to continue treatment despite these costs.


Lauren Uhler, BA

Latest:

Pilot-Testing a New Program for Providing Personalized and Patient-Centered Preventive Care

Program that enhances personalized and patient-centered preventive care at a busy inner-city primary care clinic may be associated with improved health outcomes.



Kellie J. Ryan, MPH Matthew D. Rousculp, PhD, MPH. Reply by Bruce Y. Lee, MD, MBA Julie H. Y. Tai, MD Rachel R. Bailey, MPH

Latest:

Opening and Continuing the Discussion on Influenza Vaccination Timing

A patient-centered medical home with intensive case management and a payer partner can significantly improve hospital utilization and may decrease total medical costs for a Medicare population.




Rachel Novotny, PhD

Latest:

Is Occupational Type Related to Obesity Risk?

Sociodemographic characteristics of blue-collar workers may be attributed to the higher rates of obesity and chronic disease seen among them compared with white-collar workers.




Caroline S. Carlin, PhD

Latest:

Diabetes Care Quality: Do Large Medical Groups Perform Better?

Large medical groups perform better than medium- or small-sized groups on diabetes quality measures, perhaps because they have more care management processes in place.



Troyen A. Brennan, JD, MD

Latest:

Adherence to Medication Under Mandatory and Voluntary Mail Benefit Designs

Pharmacy benefit designs that mandate mail pharmacy use interfere with prescription drug access, particularly for individuals without previous mail pharmacy experience.



Shawn J. Gagne, BA

Latest:

Quality Measurement of Medication Monitoring in the Meaningful Use Era

Shifting from claims to integrated electronic health records to calculate quality metrics will improve reported quality attributable to data capture changes, not true quality improvements.



Natalie Flaks-Manov, MPH

Latest:

EMR-Based Medication Adherence Metric Markedly Enhances Identification of Nonadherent Patients

Integration of written-prescription data into medication adherence measures doubled the number of patients identified as nonadherent and improved prediction of follow-up LDL cholesterol.


Michael Reff, RPh, MBA

Latest:

Management of MPN: Benchmarks For Quality Care

Ruben Mesa, MD, leads a discussion on key benchmarks and final thoughts about good-quality care programs for patients with MPNs, including parameters for judging efficacy and safety.


Amber Sieja, MD

Latest:

Successful Implementation of APSO Notes Across a Major Health System

In this study, the authors demonstrate widespread adoption and satisfaction with the novel APSO (Assessment, Plan, Subjective, Objective) format for progress notes at a large, integrated health delivery network.


Jeah Kyoungrae Jung, PhD

Latest:

Coverage for Hepatitis C Drugs in Medicare Part D

This study analyzes the current coverage designs for hepatitis C virus drugs by Medicare Part D plans.

AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo